Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
MedTech
InBrain unveils positive interim findings from BCI tech study
Interim analysis of the results from the first cohort of four patients enrolled in the study demonstrated no device-related adverse events.
Heather Landi
Jul 30, 2025 11:00am
Elevidys fallout hasn't dented Roche's hopes for gene therapies
Jul 25, 2025 8:30am
FDA clears Fasikl AI stimulation wristwatch for essential tremor
Jul 3, 2025 9:15am
Blocking enzyme saved mice from known Parkinson’s mechanism
Jul 2, 2025 5:26pm
Former Inhibikase CEO launches new biotech for Parkinson's asset
May 12, 2025 12:44pm
Neurocrine hands back 2 CNS gene therapy programs to Voyager
May 7, 2025 7:30am
